The CARPEM SIRIC is one of 8 integrated cancer research sites accredited by INCa for the period 2023-2027.
Since 2013, we develop precision medicine for solid and hematological tumors. It brings together the fundamental, translational and clinical oncology research expertise of the Paris CARPEM Cancer Institute (GHU APHP.Centre – Université Paris Cité, INSERM), the first Comprehensive Cancer Center of APHP to be accredited by OECI. Our research project, entitled “CARPEM3: CAncer Research in multiple dimensions to accelerate PrEcision Medicine”, aims to accelerate the implementation of precision medicine to improve the care of cancer patients.